Ernexa Therapeutics Inc. (ERNA) Total assets 2016–2025
Ernexa Therapeutics Inc. (ERNA) total assets at each fiscal year-end, per SEC filings.
$5.3MFY2025 · since FY2016: $16.4M → $5.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.3M | -89.3% |
| FY2024 | $49.1M | +120.5% |
| FY2023 | $22.3M | — |
| FY2021 | $12.9M | -8.6% |
| FY2020 | $14.1M | -5.0% |
| FY2019 | $14.9M | -10.3% |
| FY2018 | $16.6M | -0.7% |
| FY2017 | $16.7M | +1.7% |
| FY2016 | $16.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ERNA financial trends
ERNA RevenueERNA Net incomeERNA Net marginERNA Gross profitERNA Gross marginERNA Operating incomeERNA Operating marginERNA Operating cash flowERNA Free cash flowERNA Capital expendituresERNA Return on equityERNA Stock buybacksERNA Dividends paidERNA Total liabilitiesERNA Shareholders’ equityERNA overview →